Clinical Trial Update: Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial assessed zoledronic acid to prevent osteoporosis and bone fractures in men with locally advanced nonmetastatic prostate cancer receiving radiati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Prostate Cancer

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Osteoporosis, Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-11-29